Recent large-scale genetic and genomic studies have identified genetic variants associated with AMD pathophysiology [15,16], among which is sigma 2 receptor/transmembrane protein 97 (σ2R/TMEM97), also known as meningioma-associated protein (MAC30) [17,18]. Here, TMEM97 is linked to age-related macular degeneration.